Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M57.8Revenue (TTM) $M25.1Net Margin (%)-293.7Altman Z-Score-2.1
Enterprise Value $M140EPS (TTM) $-0.5Operating Margin %-270.2Piotroski F-Score2
P/E(ttm)--Beneish M-Score26.3Pre-tax Margin (%)-288.2Higher ROA y-yN
Price/Book5.310-y EBITDA Growth Rate %-22.7Quick Ratio8.1Cash flow > EarningsY
Price/Sales2.15-y EBITDA Growth Rate %-23.4Current Ratio8.6Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-29.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-374.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M146ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with OREX

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
OREXSeth Klarman 2016-03-31 Add0.16%$0.52 - $1.92
($1.32)
$ 0.40-70%Add 881.68%22,268,399
OREXSeth Klarman 2015-12-31 Add0.04%$1.57 - $3.32
($2.38)
$ 0.40-83%Add 176.17%2,268,399
OREXSeth Klarman 2015-09-30 Buy 0.03%$2.04 - $4.93
($3.44)
$ 0.40-88%New holding821,363
OREXGeorge Soros 2012-06-30 Sold Out -0.03%$3.16 - $6.37
($3.76)
$ 0.40-89%Sold Out0
OREXGeorge Soros 2012-03-31 Buy 0.03%$1.68 - $5.01
($3.11)
$ 0.40-87%New holding500,000
OREXFirst Eagle Investment 2010-09-30 Sold Out -0.01%$3.9 - $6.77
($4.98)
$ 0.40-92%Sold Out0
OREXFirst Eagle Investment 2010-06-30 Add$4.05 - $7.04
($5.57)
$ 0.40-93%Add 74.07%470,000
OREXFirst Eagle Investment 2010-03-31 Add$5.9 - $7.66
($6.55)
$ 0.40-94%Add 22.73%270,000
OREXFirst Eagle Investment 2009-12-31 Add0.01%$6.44 - $9.39
($7.57)
$ 0.40-95%Add 83.33%220,000
OREXFirst Eagle Investment 2009-09-30 Buy 0.01%$5.2 - $10.34
($7.89)
$ 0.40-95%New holding120,000
OREXBill Gates 2009-06-30 Sold Out $1.89 - $5.21
($3.19)
$ 0.40-87%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

OREX is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


OREX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Booth Mark DChief Commercial Officer 2015-02-26Sell50,000$5.68-92.96view
Turner Heather DSVP, Gen. Counsel & Secretary 2014-12-02Sell22,643$6-93.33view
Turner Heather DSVP, Gen. Counsel & Secretary 2014-11-25Sell31,388$5.83-93.14view
BOCK LOUIS CDirector 2014-11-18Buy1,325$5.58-92.83view
BOCK LOUIS CDirector 2014-11-12Buy27,052$5.57-92.82view
Turner Heather DVP, Gen. Counsel & Secretary 2014-09-22Sell300,000$4.47-91.05view
NARACHI MICHAELPresident and CEO 2014-09-15Buy50,000$4.78-91.63view
Hagan Joseph PSr. VP, Corporate Development 2014-09-15Buy5,000$4.69-91.47view
Hagan Joseph PChief Business Officer 2013-07-31Sell12,000$7.8-94.87view
Booth Mark DChief Commercial Officer 2013-07-26Sell64,767$7.55-94.7view

Quarterly/Annual Reports about OREX:

News about OREX:

Articles On GuruFocus.com
Seth Klarman’s Largest New Buys and Adds Feb 15 2016 
Value Investing in BioPharma Nov 18 2015 
Seth Klarman Buys Pharmaceutical Company's Shares to Fund Drug Launch Oct 12 2015 
Oxford Industries (OXM) Solid Growth Metrics, Orexigen Therapeutics (OREX) European Anti-Obesity App Mar 27 2015 
Orexigen Therapeutics' Bright Future Mar 03 2015 
Revisiting Arena, Orexigen, And VIVUS: Shareholders Can Recoup Their Losses By Invest In MannKind Aug 19 2014 
Weekly CEO Sells Highlight: Orexigen Therapeutics Inc, Gas Natural Inc, The Middleby Corporation, an Jul 15 2012 
Weekly CEO Sells Highlight: Gas Natural Inc, Encore Bancshares Inc, Staples Inc, and Orexigen Therap Jul 08 2012 
Arena Facing Increased Pressure from Peers Apr 23 2012 
Arena Could Dip If Lorcaserin Fails Again Apr 22 2012 

More From Other Websites
Orexigen Announces Upcoming Presentations at European Obesity Summit 2016 May 27 2016
Orexigen Therapeutics Founder and Former Chairman Eckard Weber Steps Down from Board May 27 2016
OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers May 27 2016
Orexigen Therapeutics Founder and Former Chairman Eckard Weber Steps Down from Board May 27 2016
Orexigen Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) May 26 2016
Orexigen Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) May 26 2016
Orexigen Appoints New Member of Board of Directors and Announces Senior Management Changes May 23 2016
OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... May 23 2016
Orexigen Appoints New Member of Board of Directors and Announces Senior Management Changes May 23 2016
OREXIGEN THERAPEUTICS, INC. Financials May 14 2016
OREXIGEN THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report May 05 2016
Edited Transcript of OREX earnings conference call or presentation 4-May-16 9:00pm GMT May 05 2016
OREXIGEN THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... May 04 2016
Orexigen Therapeutics Inc Earnings Call scheduled for 5:00 pm ET today May 04 2016
Orexigen reports 1Q loss May 04 2016
Orexigen reports 1Q loss May 04 2016
Orexigen Therapeutics Reports Business and Financial Results for the First Quarter Ended March 31,... May 04 2016
Orexigen Therapeutics Reports Business and Financial Results for the First Quarter Ended March 31,... May 04 2016
Q1 2016 Orexigen Therapeutics Inc Earnings Release - After Market Close May 04 2016
Orexigen Therapeutics to Speak at the Bank of America Merrill Lynch 2016 Health Care Conference May 03 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)